Study helps identify which populations of foreign-born persons living in US at higher risk of TB

User rating: 5 / 5 after 1 vote(s)

The relative yield of finding and treating latent tuberculosis is particularly high among higher-risk groups of foreign-born persons living in the U.S., such as individuals from most countries of sub-Saharan Africa and Southeast Asia, according to a study in the July 23/30 issue of JAMA.


Full story »

All News summaries from Medicine & Health news
All News summaries for July 22, 2008

Genetic variants associated with vitamin B12

13 minutes ago | User rating: not rated yet
Researchers at the Harvard School of Public Health (HSPH) and their collaborators at Tufts University and the National Cancer Institute (NCI) have identified a common genetic influence on B12 vitamin levels in the blood, ...

Antiangiogenic drugs impede chemotherapy-stimulated tumor recovery

1 hour ago | User rating: not rated yet
Scientists have gained new insight into a mechanism whereby chemotherapy may actually assist the rapid regrowth of tumors after treatment. The research, published by Cell Press in the September issue of the journal Cancer ...

Apples and oranges: Tumor blood vessel cells are remarkably atypical

1 hour ago | User rating: not rated yet
Contrary to a long-standing assumption that blood vessel cells in healthy tissues and those associated with tumors are similar, a new study unequivocally demonstrates that tumor blood vessel cells are far from normal. The ...

Premature children 4 times more likely to have behavioral disorders

3 hours ago | User rating: not rated yet
Children born prematurely are four times more likely to have emotional problems or behavioural disorders, according to research led by the University of Warwick.

Calculating how breast cancers will respond to tamoxifen

3 hours ago | User rating: not rated yet
A discovery by Australian scientists could help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.